Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,873 | -14,871 | -12,247 | -5,544 | -14,526 |
| Depreciation Amortization | 825 | 577 | 355 | 174 | 551 |
| Accounts receivable | -9 | -491 | 3 | -129 | -79 |
| Other Working Capital | 2,364 | 250 | 995 | -39 | -2,171 |
| Other Operating Activity | 5,679 | 4,914 | 5,262 | 3,022 | 5,802 |
| Operating Cash Flow | $-13,014 | $-9,621 | $-5,632 | $-2,516 | $-10,423 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -519 | -501 | -353 | -227 | 3,389 |
| Investing Cash Flow | $-519 | $-501 | $-353 | $-227 | $3,389 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | -400 |
| Common Stock Issued | 42,387 | 1,169 | 150 | N/A | 36,052 |
| Common Stock Repurchased | 150 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $42,537 | $1,169 | $150 | $N/A | $35,652 |
| Beginning Cash Position | 40,138 | 40,138 | 40,138 | 40,138 | 11,520 |
| End Cash Position | 69,142 | 31,185 | 34,303 | 37,395 | 40,138 |
| Net Cash Flow | $29,004 | $-8,953 | $-5,835 | $-2,743 | $28,618 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,014 | -9,621 | -5,632 | -2,516 | -10,423 |
| Capital Expenditure | -519 | -501 | -353 | -227 | -308 |
| Free Cash Flow | -13,533 | -10,122 | -5,985 | -2,743 | -10,731 |